KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Revenue: 2015-2025

Historic Revenue for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to $1.4 billion.

  • BeOne Medicines' Revenue rose 41.00% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 billion, marking a year-over-year increase of 49.92%. This contributed to the annual value of $3.8 billion for FY2024, which is 54.96% up from last year.
  • As of Q3 2025, BeOne Medicines' Revenue stood at $1.4 billion, which was up 7.37% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Revenue registered a high of $1.4 billion during Q3 2025, and its lowest value of $150.0 million during Q2 2021.
  • In the last 3 years, BeOne Medicines' Revenue had a median value of $929.2 million in 2024 and averaged $919.4 million.
  • Per our database at Business Quant, BeOne Medicines' Revenue skyrocketed by 1,063.82% in 2021 and then plummeted by 49.39% in 2022.
  • Quarterly analysis of 5 years shows BeOne Medicines' Revenue stood at $214.0 million in 2021, then soared by 77.63% to $380.1 million in 2022, then soared by 66.91% to $634.4 million in 2023, then surged by 77.78% to $1.1 billion in 2024, then skyrocketed by 41.00% to $1.4 billion in 2025.
  • Its Revenue stands at $1.4 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.1 billion for Q1 2025.